Back to funds

Ally Bridge Group (NY) LLC

Updated 6 days ago

Managed by Ally Bridge Group (Ny) Llc • Latest filing Q3 2026

Portfolio value
$76M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
57.1%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$96M
Q1 2026$123.8M
Q2 2026$113.1M
Q3 2026$76M

Top holdings

18 positions as of Q3 2026

View filing
D

DEFINIUM THERAPEUTICS INC

Value
$15.2M
Shares
400.0K
% Port
20.02%
A

ABIVAX SA

Value
$12.4M
Shares
125.0K
% Port
16.28%
E

EDGEWISE THERAPEUTICS INC

Value
$7.5M
Shares
185.4K
% Port
9.90%
P

PROMIS NEUROSCIENCES INC

Value
$6.7M
Shares
620.3K
% Port
8.85%
N

MINERVA NEUROSCIENCES INC

Value
$5.5M
Shares
1.66M
% Port
7.29%
A

AMYLYX PHARMACEUTICALS INC

Value
$5.3M
Shares
182.0K
% Port
6.96%
S

SHATTUCK LABS INC

Value
$4.3M
Shares
625.2K
% Port
5.61%
O

OBSIDIAN THERAPEUTICS INC

Value
$4.2M
Shares
302.4K
% Port
5.46%
A

ALUMIS INC

Value
$3M
Shares
400.0K
% Port
3.89%
?
10.N/A

AN2 THERAPEUTICS INC

Value
$2.8M
Shares
526.3K
% Port
3.68%
E

EUPRAXIA PHARMACEUTICALS INC

Value
$2.1M
Shares
231.1K
% Port
2.77%
?
12.N/A

COMPASS THERAPEUTICS INC

Value
$2.1M
Shares
2.00M
% Port
2.74%
A

AVALO THERAPEUTICS INC

Value
$2.1M
Shares
134.4K
% Port
2.71%
I

INVENTIVA SA

Value
$839K
Shares
227.3K
% Port
1.10%
V

VOGENX INC

Value
$745K
Shares
32.7K
% Port
0.98%
T

TRAWS PHARMA INC

Value
$467K
Shares
786.2K
% Port
0.61%
?
17.N/A

PERSPECTIVE THERAPEUTICS INC

Value
$450K
Shares
163.6K
% Port
0.59%
A

ASSEMBLY BIOSCIENCES INC

Value
$430K
Shares
18.3K
% Port
0.57%

Explore